Bulletin
Investor Alert

New York Markets Open in:

Allakos Inc.

NAS: ALLK

GO
/marketstate/country/us

Before the Bell

 --Real time quotes

May 23, 2022, 4:34 a.m.

/zigman2/quotes/203639566/composite

$

3.14

Change

+0.14 +4.67%

Volume

Volume 1

Real time quotes

/zigman2/quotes/203639566/composite

Previous close

$ 3.00

$ 3.00

Change

-0.02 -0.66%

Day low

Day high

$2.84

$3.09

Open

52 week low

52 week high

$2.77

$112.87

Open

Robert Alexander

Presently, Robert Alexander is Chief Executive Officer & Director at Allakos, Inc.

In the past Dr. Alexander held the position of Director at Alta Partners Management Corp., Principal at MPM Capital Inc and Principal at MPM BioEquities Adviser LLC (a subsidiary of MPM Capital Inc), Executive Chairman & Chief Executive Officer of SARcode Bioscience, Inc., Chief Executive Officer of ZS Pharma, Inc., Principal at Genentech, Inc. and Managing Partner at TL Ventures LP.

Robert Alexander received an undergraduate degree from Miami University and a doctorate from The University of North Carolina at Asheville.

Transactions

Date Shares Transaction Value
03/02/2022 8,215   Derivative/Non-derivative trans. at $5.38 per share. 44,197
02/25/2022 529,323   Award at $0 per share. 0
12/02/2021 20,241   Derivative/Non-derivative trans. at $78.69 per share. 1,592,765
12/01/2021 51,681   Award at $0 per share. 0
09/02/2021 3,985   Derivative/Non-derivative trans. at $91.66 per share. 365,266
06/04/2021 5,482   Disposition at $89.64 per share. 491,407
06/04/2021 3,597   Disposition at $89.62 per share. 322,364
06/04/2021 14,516   Derivative/Non-derivative trans. at $0.69 per share. 10,016
06/04/2021 14,516   Disposition at $89.64 per share. 1,301,215
06/03/2021 14,517   Derivative/Non-derivative trans. at $0.69 per share. 10,016
06/03/2021 14,517   Disposition at $92.14 per share. 1,337,597
06/03/2021 4,003   Derivative/Non-derivative trans. at $92.2 per share. 369,077
06/03/2021 5,484   Disposition at $92.09 per share. 505,022
06/02/2021 14,517   Derivative/Non-derivative trans. at $0.69 per share. 10,016
06/02/2021 14,517   Disposition at $94.55 per share. 1,372,583
06/02/2021 5,484   Disposition at $94.56 per share. 518,568
05/19/2021 5,482   Disposition at $98.89 per share. 542,115
05/19/2021 14,516   Derivative/Non-derivative trans. at $0.69 per share. 10,016
05/19/2021 14,516   Disposition at $98.94 per share. 1,436,214
05/18/2021 5,484   Disposition at $102.29 per share. 560,959
05/18/2021 14,517   Derivative/Non-derivative trans. at $0.69 per share. 10,016
05/18/2021 14,517   Disposition at $102.32 per share. 1,485,380
05/17/2021 5,484   Disposition at $99.69 per share. 546,700
05/17/2021 14,517   Derivative/Non-derivative trans. at $0.69 per share. 10,016
05/17/2021 14,517   Disposition at $99.68 per share. 1,447,055
03/17/2021 20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
03/17/2021 20,000   Disposition at $121.14 per share. 2,422,800
03/16/2021 20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
03/16/2021 20,000   Disposition at $121.76 per share. 2,435,200
03/15/2021 20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
03/15/2021 20,000   Disposition at $122.78 per share. 2,455,600
03/02/2021 3,890   Derivative/Non-derivative trans. at $117.82 per share. 458,320
12/29/2020 8,240   Derivative/Non-derivative trans. at $4.31 per share. 35,514
12/02/2020 14,501   Derivative/Non-derivative trans. at $99.04 per share. 1,436,180
12/01/2020 121,600   Award at $0 per share. 0
11/29/2019 121,600   Award at $0 per share. 0

Officers and Executives

Dr. Robert Alexander
Chief Executive Officer & Director
Dr. Adam L. Tomasi
President & Chief Operating Officer
Mr. Harlan Baird Radford
Chief Financial Officer
Dr. Ruby Casareno
Vice President-Technical Operations
Dr. Craig Paterson
Chief Medical Officer
Mr. Roland K. Winger
Senior Vice President
Mr. Meg Fitzgerald
Secretary, Chief Compliance Officer & Senior VP
Dr. Sally D. Bolmer
Vice President-Regulatory Affairs & Development
Mr. Alex Schwartz
Vice President-Investor Relations
Mr. Daniel S. Janney
Chairman
Dr. John P. McKearn
Independent Director
Mr. Steven P. James
Independent Director
Mr. Paul E. Walker
Independent Director
Mr. Robert E. Andreatta
Independent Director
Link to MarketWatch's Slice.